<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">In February 2016, the World Health Organization (WHO) declared ZIKV to be a Public Health Emergency of International Concern (PHEIC) [
 <xref rid="bib13" ref-type="bibr">13</xref>]. Strategies of fighting ZIKV infection include the development of vaccines and the screening of antiviral agents that inhibit different stages of the viral life cycle [
 <xref rid="bib14" ref-type="bibr">14</xref>]. Unfortunately, no approved antiviral ZIKV agents are currently available. There is thus an urgent need to develop safe and effective antiviral agents against ZIKV and to elucidate their mechanisms. Doing so should help identify lead compounds which have the potential for further clinical development in the fight against ZIKV.
</p>
